retatrutide clinical trials brazil Phase 3: TRIUMPH Program Results 2026 Retatrutide, an investigational triple hormone

Obesity is a chronic medical condition characterized by dysregulated appetite hormones, altered metabolism, and biological defense of elevated body weight

This delay in recognition can allow a simple bladder infection to progress to a more serious kidney infection

Others may allow a direct switch if dosing intervals align and side effects are minimal

A maintenance strategy matters: nutrition, resistance training, follow-up, medication adjustment, dose reduction, switching, or continued therapy depending on the patient

However, like all medications, it comes with its own set of side effects

ClinicalTrials.gov identifier: NCT02453711